Sökresultat

We use positron emission tomography to elucidate disease mechanisms, monitor disease progression, and improve diagnosis in neurodegenerative disorders. Our group leads the PET imaging program within the BioFINDER studies, integrating tau PET, amyloid PET, dopamine transporter imaging, and cardiac sympathetic nervous system imaging. These modalities are combined with extensive biomarker profiling,

https://www.multipark.lu.se/pet-imaging-neurodegenerative-diseases - 2026-08-17

We focus on developing accurate methods for the early diagnosis of neurodegenerative diseases, e.g., Alzheimer's and Parkinson's disease. Our research also aims to unravel the pathological events in humans during the pre-symptomatic and prodromal stages. Finally, we work to improve clinical trials evaluating new disease-modifying therapies. An overview of our research cohorts can be found at BioFI

https://www.multipark.lu.se/clinical-memory-research-unit-0 - 2026-08-17

Frontotemporal dementia is the second most common neurodegenerative dementing disorder. Our research focuses on two main areas: improving the diagnostic process through the use of biomarkers and understanding the core mechanisms of the disease. To achieve these aims, we use a variety of methods, including PET, MRI, and genetic analyses.Our research contributes to improved diagnosis of frontotempor

https://www.multipark.lu.se/frontotemporal-dementia-research-unit - 2026-08-17

Our research We are interested in how gene expression is regulated in the brain and how this process influences human brain evolution, neurodegenerative diseases, psychiatric disorders, and brain tumors. Our current focus is to study the role of epigenetic mechanisms and transposable elements. Our technical expertise includes CRISPR, reprogramming, bioinformatics, single-cell analysis, and human s

https://www.multipark.lu.se/laboratory-molecular-neurogenetics - 2026-08-17

Huntington’s disease (HD) is characterised by classical neurological symptoms, and there is currently no disease-modifying therapy. Today, huntingtin-silencing strategies targeting the brain provide hope for HD patients and their families. However, pathology in HD is not limited to the brain. The causative gene, mutant huntingtin, is widely expressed throughout the body. Our research focuses on un

https://www.multipark.lu.se/brain-disease-biomarker-unit - 2026-08-17

Our research aims to uncover early mechanisms and biomarkers involved in neurodegenerative disorders such as Alzheimer’s disease and dementia with Lewy bodies. Our strategy is to examine how risk factors, including stress, inflammation, metabolic disturbances, and amyloidogenesis, affect cellular integrity in the brain and retina.We use a translational approach in which our hypotheses are built up

https://www.multipark.lu.se/cognitive-disorder-research-unit - 2026-08-17

Our research Motor impairments are common among people with neurodegenerative diseases such as Parkinson’s disease (PD). In older people in general, some motor abilities seem to decline prior to the development of a major neurocognitive disorder, i.e. dementia. Our research primarily involves patients with PD and those at risk of developing dementia. We address health from a broad perspective, inc

https://www.multipark.lu.se/rehabmotor-aspects - 2026-08-17

Flow Cytometry Analysis and Fluorecence Activated Cell Sorting (FACS) Flow cytometry enables measurement of fluorescence intensity of particles (cells) in a liquid stream. Analysis of live and fixed cells may be based on size, granularity/complexity, fluorescent proteins, cell surface antigen expression, intracellular antigen expression, DNA content. Flow cytometry is ideal for multiplexing target

https://www.multipark.lu.se/infrastructures/facs-platform - 2026-08-17

PROGRAM 2026 15 May, 15:00, Segerfalksalen, BMC A10Speaker: Juho Joutsa, MD, PhD Professor of neurology, University of Turku, Finland. Lecture title: Post-stroke movement disordersLecture host: Professor Per OdinAbout the speaker:Prof. Joutsa is a movement disorder neurologist with special interest in lesion-induced symptoms andneuromodulation (rTMS, DBS, MRgFUS). He completed his postdoctoral res

https://www.multipark.lu.se/lund-university-neuroscience-graduate-school/frontiers-neuroscience-seminar-series - 2026-08-17

MultiPark’s innovation grants intend to foster translation of scientific discoveries to inventions that can be protected by patents to yield societal impact in the long term. Since 2011, MultiPark has funded 21 innovation projects with a total of 3.8 MSEK.So far, the innovation support has sparked remarkable achievements: 4 discoveries commercialized6 patents filed4 companies established2 propriet

https://www.multipark.lu.se/multipark-innovation-outcomes - 2026-08-17

3 September 2026 08:30 to 4 September 2026 15:00 | Conference Welcome to this year's MultiPark retreat that will take place from Thursday, September 3 to Friday, September 4 at Hotel Öresund in Landskrona!An email with the registration link for the retreat was sent out to MultiPark members and associated members on May 6. The last day to register was Sunday, May 31 at 23.59. If you did not receive

https://www.multipark.lu.se/calendar/multipark-annual-retreat-2026 - 2026-08-17

Information and support for the MultiPark research community MultiPark Retreat 2025. Photo: Kennet Ruona Welcome to MultiPark — where research grows through collaboration! What MultiPark can do for youGet access to a wide variety of equipment, technical platforms, and know-how to advance your research through MultiPark’s infrastructures.Support for larger grant applications from MultiPark’s Grant

https://www.multipark.lu.se/multipark-internal - 2026-08-17

From now on, annual news emails will replace the previous newsletters.  Keep yourself updated on this page.On the newly launched Internal MultiPark page: https://www.multipark.lu.se/internal, you will find a list of links about how MultiPark can support your research, our new sub-logotype, and materials to promote MultiPark when presenting your research. New MultiParkersWe are happy to introduce P

https://www.multipark.lu.se/multipark-community-updates - 2026-08-17

The Grant Manager, Pomme Rigter, helps MultiPark’s researchers with many aspects of grant applications, focusing primarily on European grants, while also supporting national calls. Pomme Rigter holds a PhD and has postdoctoral experience in neuroscience. With strong research expertise and broad technical knowledge, she helps improve the clarity, structure, flow, and content of grant proposals.Serv

https://www.multipark.lu.se/multiparks-grant-manager - 2026-08-17

MultiPark Innovation supports the transformation of scientific discoveries into innovations that benefit patients and society. Commercializing inventions generated by research in Multipark, is one of MultiPark’s missions, also reflecting the Swedish Government’s intention to promote Innovation as the third mission of universities alongside research and education.Since 2011, Multipark has continuou

https://www.multipark.lu.se/innovation - 2026-08-17

MultiPark researchers regularly contribute to The Conversation, an international platform where academics share research findings and expert perspectives with a broad audience. Articles in The Conversation are written by researchers and published in collaboration with journalists to make current research accessible and relevant to the public. Below is a list of articles by MultiPark researchers pu

https://www.multipark.lu.se/multipark-research-featured-conversation - 2026-08-17

Information on the rat behavioural platform Test roomsThe rat behavioural platform is located in BMC A0931 and A0932.The following equipment is available for use:ANY-Maze-tracked testsCompulsive checking test (2 total)Conditioned place preference (8 total)Elevated plus mazeIowa gambling task (2 total)Open field3 arenas (1m x 1m) in standing support8 arenas (0.8m x 0.8m) floor mountedOther testsCor

https://www.multipark.lu.se/infrastructures/behavioural-platforms/rat-behavioural-platform - 2026-08-17

The Terminal Node is an in vivo platform supported by MultiPark. For more information about the Terminal Node, please visit the Terminal Node SharePoint page (LU login required). Terminal Node on SharePoint LU login required

https://www.multipark.lu.se/infrastructures/terminal-node - 2026-08-17

We investigate how neural circuits and neuroimmune interactions regulate emotional and cognitive functions in health and disease. Our research focuses on how microglia modulate microcircuit plasticity during emotional behaviors and neuroinflammation, and how these processes contribute to psychiatric and neurodegenerative disorders.We combine in vivo calcium imaging using miniature microscopes and

https://www.multipark.lu.se/neural-circuits-emotion - 2026-08-17

We develop novel techniques for safe and efficient targeted delivery of genetic material to the human brain. We combine adeno-associated viral vector engineering with structurally guided artificial intelligence and spatial sequencing to develop novel vectors that can reach the target cell type. By gaining a deep understanding of the target cells and their surface receptors, we can tailor AAVs to a

https://www.multipark.lu.se/molecular-neuromodulation - 2026-08-17